Collagen Powder Vanilla
Youtheory

Collagen Powder Vanilla

C+
N+ Score74
Collagen & BeautyServing: 7.7 Gram(s)Type: Other Combinations

Collagen Powder Vanilla is a targeted beauty supplement, categorized as an "Other Combination" within the Collagen & Beauty category, containing 3 key ingredients. It holds an N+ Score of 74 and a C+ grade, reflecting a good quality profile. Notably, Hydrolyzed Collagen is present at a clinically studied dose of 6000 mg, which research suggests may support skin health and elasticity, alongside Vitamin C at 200 mg, also at a clinical dose, potentially aiding collagen synthesis. Biotin, however, is identified as underdosed in this formulation. With 100% label transparency, consumers can clearly identify the dosages of these ingredients, making it a straightforward option for those focusing on collagen intake.

About This Product

Collagen Powder Vanilla by Youtheory is a collagen & beauty supplement containing 3 active ingredients. It has earned an N+ Score of 74/100 (Grade C+).

Notable clinical-dose ingredients include Vitamin C, hydrolyzed Collagen.

N+ Score Breakdown

Ingredient Adequacy67/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness67/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity72/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • No major weaknesses identified

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Biotin2.500 mgUnder
Vitamin C200.000 mgOptimal
hydrolyzed Collagen6000.000 mgHigh

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.